Cargando…
Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030738/ https://www.ncbi.nlm.nih.gov/pubmed/29970126 http://dx.doi.org/10.1186/s13045-018-0633-1 |
| _version_ | 1783337182584373248 |
|---|---|
| author | Huang, Qian Xi, Jiajia Wang, Lei Wang, Xu Ma, Xiaodong Deng, Qipan Lu, Yong Kumar, Munish Zhou, Zhiyuan Li, Ling Zeng, Zhaoyang Young, Ken H. Yi, Qing Zhang, Mingzhi Li, Yong |
| author_facet | Huang, Qian Xi, Jiajia Wang, Lei Wang, Xu Ma, Xiaodong Deng, Qipan Lu, Yong Kumar, Munish Zhou, Zhiyuan Li, Ling Zeng, Zhaoyang Young, Ken H. Yi, Qing Zhang, Mingzhi Li, Yong |
| author_sort | Huang, Qian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6030738 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60307382018-07-09 Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy Huang, Qian Xi, Jiajia Wang, Lei Wang, Xu Ma, Xiaodong Deng, Qipan Lu, Yong Kumar, Munish Zhou, Zhiyuan Li, Ling Zeng, Zhaoyang Young, Ken H. Yi, Qing Zhang, Mingzhi Li, Yong J Hematol Oncol Correction BioMed Central 2018-07-03 /pmc/articles/PMC6030738/ /pubmed/29970126 http://dx.doi.org/10.1186/s13045-018-0633-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Huang, Qian Xi, Jiajia Wang, Lei Wang, Xu Ma, Xiaodong Deng, Qipan Lu, Yong Kumar, Munish Zhou, Zhiyuan Li, Ling Zeng, Zhaoyang Young, Ken H. Yi, Qing Zhang, Mingzhi Li, Yong Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy |
| title | Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy |
| title_full | Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy |
| title_fullStr | Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy |
| title_full_unstemmed | Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy |
| title_short | Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy |
| title_sort | correction to: mir-153 suppresses ido1 expression and enhances car t cell immunotherapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030738/ https://www.ncbi.nlm.nih.gov/pubmed/29970126 http://dx.doi.org/10.1186/s13045-018-0633-1 |
| work_keys_str_mv | AT huangqian correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT xijiajia correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT wanglei correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT wangxu correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT maxiaodong correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT dengqipan correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT luyong correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT kumarmunish correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT zhouzhiyuan correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT liling correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT zengzhaoyang correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT youngkenh correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT yiqing correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT zhangmingzhi correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy AT liyong correctiontomir153suppressesido1expressionandenhancescartcellimmunotherapy |